Bronchodilator Therapy in COPD

被引：0
作者：
Kirsten, A. -M. [1 ]
Watz, H. [1 ]
Magnussen, H. [1 ]
机构：
[1] Mitglied Deutsch Zentrum Lungenforsch, Airway Res Ctr North, LungenClin Grosshansdorf, Pneumol Forschungsinst, Grosshansdorf, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2014年 / 139卷 / 06期
关键词：
COPD; Bronchodilatatoren; LABA; LAMA; bronchodilators; OBSTRUCTIVE PULMONARY-DISEASE; TIOTROPIUM; EXACERBATIONS; PREVENTION; INHALER;
D O I：
10.1055/s-0033-1360019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：264 / 267
页数：4
相关论文
共 13 条
  • [1] Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase IIIb Study
    Beier, Jutta
    Kirsten, Anne-Marie
    Mroz, Robert
    Segarra, Rosa
    Chuecos, Ferran
    Caracta, Cynthia
    Garcia Gil, Esther
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (04) : 511 - 522
  • [2] Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study
    Decramer, Marc L.
    Chapman, Kenneth R.
    Dahl, Ronald
    Frith, Peter
    Devouassoux, Gilles
    Fritscher, Carlos
    Cameron, Ray
    Shoaib, Muhammad
    Lawrence, David
    Young, David
    McBryan, Danny
    [J]. LANCET RESPIRATORY MEDICINE, 2013, 1 (07) : 524 - 533
  • [3] Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials
    Dransfield, Mark T.
    Bourbeau, Jean
    Jones, Paul W.
    Hanania, Nicola A.
    Mahler, Donald A.
    Vestbo, Jorgen
    Wachtel, Andrew
    Martinez, Fernando J.
    Barnhart, Frank
    Sanford, Lisa
    Lettis, Sally
    Crim, Courtney
    Calverley, Peter M. A.
    [J]. LANCET RESPIRATORY MEDICINE, 2013, 1 (03) : 210 - 223
  • [4] Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services
    Hawkins, Nathaniel M.
    Virani, Sean
    Ceconi, Claudio
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (36) : 2795 - +
  • [5] Real World COPD: Association of Morning Symptoms with Clinical and Patient Reported Outcomes
    Roche, Nicolas
    Small, Mark
    Broomfield, Sarah
    Higgins, Victoria
    Pollard, Ryan
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (06) : 679 - 686
  • [6] Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
    Singh, Sonal
    Loke, Yoon K.
    Enright, Paul
    Furberg, Curt D.
    [J]. THORAX, 2013, 68 (01) : 114 - 116
  • [7] Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials
    Singh, Sonal
    Loke, Yoon K.
    Enright, Paul L.
    Furberg, Curt D.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [8] Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
    Tashkin, Donald P.
    Ferguson, Gary T.
    [J]. RESPIRATORY RESEARCH, 2013, 14
  • [9] Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease GOLD Executive Summary
    Vestbo, Jorgen
    Hurd, Suzanne S.
    Agusti, Alvar G.
    Jones, Paul W.
    Vogelmeier, Claus
    Anzueto, Antonio
    Barnes, Peter J.
    Fabbri, Leonardo M.
    Martinez, Fernando J.
    Nishimura, Masaharu
    Stockley, Robert A.
    Sin, Don D.
    Rodriguez-Roisin, Roberto
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (04) : 347 - 365
  • [10] Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
    Vogelmeier, Claus
    Hederer, Bettina
    Glaab, Thomas
    Schmidt, Hendrik
    Rutten-van Molken, Maureen P. M. H.
    Beeh, Kai M.
    Rabe, Klaus F.
    Fabbri, Leonardo M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12) : 1093 - 1103
12